ArticleOncotarget2017

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.

Noelia Purroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.